Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial Journal Article


Authors: Serrano, P. E.; Parpia, S.; Karanicolas, P.; Gallinger, S.; Wei, A. C.; Simunovic, M.; Bhandari, M.; Levine, M.
Article Title: Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial
Abstract: Background and Objectives: We tested the feasibility of a simultaneous resection clinical trial in patients with synchronous colorectal cancer liver metastases to obtain the necessary information to plan a randomized trial. Methods: Multicenter feasibility single-arm trial enrolling patients with synchronous colorectal cancer liver metastases eligible for simultaneous resection. Prespecified criteria for feasibility were: proportion of eligible patients enrolled ≥66%, and the proportion of enrolled patients who completed simultaneous resection ≥75%. The prespecified 90-day major postoperative complication rate was 30%. Results: Of 61 eligible patients from February 2017 to August 2019, 41 were enrolled (67%; 95% confidence interval [CI], 55%–78%), 32 underwent simultaneous resection (78%; 95% CI, 63%–88%). Four patients were not enrolled due to the surgeon's preference, three were due to the complexity of resection (right hepatectomy and low anterior resection). Intraoperative complications during liver resection (n = 4) and progression of disease (n = 4) were the main reasons for not undergoing simultaneous resection. The 90-day incidence of major complications was 41% (95% CI, 16%–58%) and the 90-day postoperative mortality was 6% (95% CI, 1.7%–20%). Conclusion: According to prespecified criteria, enrolling patients with synchronous colorectal cancer liver metastases to a trial of simultaneous resection is feasible; however, it is associated with higher than anticipated 90-day postoperative complications. © 2021 Wiley Periodicals LLC.
Keywords: adult; controlled study; aged; middle aged; cancer surgery; major clinical study; clinical trial; cancer growth; liver neoplasms; cancer radiotherapy; follow up; follow-up studies; antineoplastic agent; laparoscopy; prospective study; prospective studies; colorectal cancer; pathology; postoperative complication; colorectal neoplasms; liver metastasis; feasibility study; pilot study; feasibility studies; multicenter study; colorectal tumor; liver tumor; liver resection; surgical mortality; hepatectomy; postoperative hemorrhage; hemicolectomy; canada; multiple cancer; neoplasms, multiple primary; colorectal liver metastases; peroperative complication; clinical outcome; social interaction; wedge resection; preoperative chemotherapy; feasibility; procedures; synchronous metastases; palliative chemotherapy; humans; prognosis; human; male; female; article; hemihepatectomy; simultaneous resection
Journal Title: Journal of Surgical Oncology
Volume: 125
Issue: 4
ISSN: 0022-4790
Publisher: Wiley Blackwell  
Date Published: 2022-03-15
Start Page: 671
End Page: 677
Language: English
DOI: 10.1002/jso.26764
PUBMED: 34878649
PROVIDER: scopus
PMCID: PMC9896571
DOI/URL:
Notes: Article -- Export Date: 1 March 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alice Chia-Chi Wei
    197 Wei